Literature DB >> 29210008

Development and surgical removal of an epiretinal membrane in infantile nystagmus syndrome: a new type of oscillopsia.

Louis F Dell'Osso1,2, Suber S Huang3.   

Abstract

PURPOSE: To report and discuss a focal oscillopsia in a small area of the visual field produced by, and after the removal of, an epiretinal membrane (ERM) in an individual with infantile nystagmus syndrome (INS) since birth with no associated afferent visual deficits. STUDY
DESIGN: A retrospective case report.
METHODS: A chart review, including clinical and electrophysiological data. A 74 y/o man with INS and an epiretinal membrane was studied. Detailed studies of the retina post-removal of an epiretinal membrane, with consequent changes in best-corrected visual acuity (BCVA), and subjective oscillopsia compared to INS waveforms. OCT measurements and eye-movement data from digital video and scleral search-coil systems were used.
RESULTS: The monocular ERM produced an unexpected focal area of torsional/vertical oscillopsia (noted 1 year prior to the ERM surgery) in the portion of the visual field that corresponded with distortions from the ERM. The remainder of the visual field, corresponding with normal healthy retina was unaffected and stable in all planes. Post-removal, BCVA improved with redevelopment of the foveal pit and focal oscillopsia became less noticeable but remained due to the retinal distortion.
CONCLUSIONS: In patients with INS, complete oscillopsia suppression across the visual field requires undistorted vision. If a retinal area of visual distortion develops or results from retinal surgery, a symptomatic island of oscillopsia in one or more planes may result.

Entities:  

Keywords:  Epiretinal membrane; Nystagmus; Oscillopsia; Surgery

Mesh:

Year:  2017        PMID: 29210008     DOI: 10.1007/s10384-017-0550-9

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  15 in total

Review 1.  Perception of a clear and stable visual world with congenital nystagmus.

Authors:  H E Bedell
Journal:  Optom Vis Sci       Date:  2000-11       Impact factor: 1.973

2.  Sensitivity to oscillatory target motion in congenital nystagmus.

Authors:  H E Bedell
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-04       Impact factor: 4.799

3.  Oscillopsia and tolerance to retinal image movement in congenital nystagmus.

Authors:  R V Abadi; J P Whittle; R Worfolk
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-02       Impact factor: 4.799

4.  Oscillopsia, retinal image stabilization and congenital nystagmus.

Authors:  R J Leigh; L F Dell'Osso; S S Yaniglos; S E Thurston
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-02       Impact factor: 4.799

5.  Onset of oscillopsia after visual maturation in patients with congenital nystagmus.

Authors:  R W Hertle; E J FitzGibbon; J M Avallone; E Cheeseman; E K Tsilou
Journal:  Ophthalmology       Date:  2001-12       Impact factor: 12.079

6.  Congenital nystagmus waveforms and foveation strategy.

Authors:  L F Dell'Osso; R B Daroff
Journal:  Doc Ophthalmol       Date:  1975-11-21       Impact factor: 2.379

7.  Motor and sensory characteristics of infantile nystagmus.

Authors:  R V Abadi; A Bjerre
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

8.  Intermittent oscillopsia in a case of congenital nystagmus. Dependence upon waveform.

Authors:  L A Abel; I M Williams; L Levi
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-11       Impact factor: 4.799

9.  Convergent-divergent pendular nystagmus: possible role of the vergence system.

Authors:  L Averbuch-Heller; A Z Zivotofsky; B F Remler; V E Das; L F Dell'Osso; R J Leigh
Journal:  Neurology       Date:  1995-03       Impact factor: 9.910

10.  Extraretinal signals for congenital nystagmus.

Authors:  H E Bedell; D C Currie
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-06       Impact factor: 4.799

View more
  1 in total

Review 1.  Update on Nystagmus and Other Ocular Oscillations.

Authors:  Seong Hae Jeong; Ji Soo Kim
Journal:  J Clin Neurol       Date:  2021-07       Impact factor: 3.077

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.